What is the expected growth forecast for the Tuberculosis Testing and Diagnostics market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Tuberculosis Testing and Diagnostics market?

Increasing prevalence of tuberculosis and advancements in diagnostic technologies are key drivers.

What are the major challenges faced by the Tuberculosis Testing and Diagnostics market?

Limited access to diagnostic facilities and lack of awareness in developing countries are major challenges.

Which regions are leading the Tuberculosis Testing and Diagnostics market?

North America and Europe are leading the market due to high adoption of advanced diagnostic technologies.

Who are the top companies in the Tuberculosis Testing and Diagnostics market?

Top companies include Roche, Abbott, and Siemens Healthineers, offering a range of diagnostic solutions.

What are the future opportunities in the Tuberculosis Testing and Diagnostics market?

Emerging economies and point-of-care diagnostic technologies present significant future opportunities.

How is technology impacting the Tuberculosis Testing and Diagnostics market?

Advances in molecular diagnostics and digital health technologies are transforming the market landscape.

What is the current regulatory landscape for the Tuberculosis Testing and Diagnostics market?

Regulatory frameworks are evolving to support innovation and ensure diagnostic test quality and safety.

What is the future outlook for the Tuberculosis Testing and Diagnostics market size?

The market size is expected to reach USD 2.5 billion by 2033, driven by growing demand for diagnostic tests.

Tuberculosis Testing and Diagnostics Value Chain Analysis & Forecast Outlook 2033

Tuberculosis Testing and Diagnostics by Application (Hospitals and Clinics, Diagnostic Laboratories, Others), by Types (Smear Microscopy, Nucleic Acid Testing, Radiography, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $12.9 million

CAGR: 4.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $12.9 million

CAGR: 4.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Tuberculosis Testing and Diagnostics Market Size | CAGR 4.5 Forecast 2033

Tuberculosis Testing and Diagnostics Value Chain Analysis & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $12.9 million

CAGR: 4.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $12.9 million

CAGR: 4.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Tuberculosis Testing and Diagnostics Market Overview

The Tuberculosis Testing and Diagnostics market refers to the industry that provides diagnostic tests and tools to detect and monitor tuberculosis. As the Tuberculosis Testing and Diagnostics market size is expected to grow, driven by increasing tuberculosis cases and advancements in diagnostic technologies, it is essential to understand the growth outlook and market forecast to navigate the industry expansion. The scope of this market encompasses various diagnostic tests, including molecular, microbiological, and immunological tests, as well as radiological and laboratory-based diagnostics. According to recent estimates, the current Tuberculosis Testing and Diagnostics market size is approximately $1.4 billion, with a projected growth forecast of 4.5% CAGR during the forecast period, driven by macro drivers such as increasing healthcare expenditure and government initiatives to combat tuberculosis.

Loading chart…

Key forces shaping the Tuberculosis Testing and Diagnostics industry include technology shifts towards molecular diagnostics, regulations and guidelines set by health organizations, and changing consumer behavior towards preventive healthcare. The largest region in the Tuberculosis Testing and Diagnostics market is Asia-Pacific, while the fastest-growing region is expected to be Latin America. As the market continues to evolve, driven by competitive intensity and supply-chain dynamics, it is crucial for stakeholders to stay informed about the latest trends and developments to capitalize on emerging opportunities and stay ahead of the competition.

Report Overview

Report Attribute	Details
Market size value in 2025	12.90 million
Revenue forecast in 2033	18.35 million
Growth rate	CAGR of 4.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Thermo Fischer Scientific; Becton Dickinson; Abbott; Hologic; Qiagen; Sanofi; Oxford Immunotec; BioMerieux; Par Sterile; Bio-Rad Laboratories; Akonni Biosystems; Cepheid; Siemens Healthineer; Hain Lifescience; Epistem; Creative Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Tuberculosis Testing and Diagnostics market is experiencing a significant transformation, driven by various factors that impact its growth forecast. The market dynamics are influenced by several key elements, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Increasing Tuberculosis Testing and Diagnostics market size due to the rising prevalence of tuberculosis, particularly in developing countries, where the disease is more common

Advances in diagnostic technologies, such as molecular diagnostics and rapid diagnostic tests, which enable faster and more accurate detection of tuberculosis

Restraints2 items

Limited access to diagnostic facilities and services in resource-poor settings, which hinders the growth forecast of the Tuberculosis Testing and Diagnostics market

High costs associated with advanced diagnostic technologies, making them less affordable for many healthcare systems, particularly in low- and middle-income countries

Opportunities2 items

Growing demand for point-of-care diagnostic tests, which can increase access to tuberculosis diagnosis and treatment in remote and resource-limited areas

Emerging markets, such as Asia-Pacific and Latin America, which offer significant opportunities for growth due to their large and growing populations

Challenges2 items

Stringent regulatory requirements, which can delay the approval and launch of new diagnostic products, impacting the Tuberculosis Testing and Diagnostics market size

Competition from established players, which can make it challenging for new entrants to gain market share and achieve a significant growth forecast

Market Segmentation

Loading chart…

The Application segment of the Tuberculosis Testing and Diagnostics market refers to the various uses of tuberculosis testing and diagnostic products. This includes diagnosis, treatment monitoring, and disease surveillance. Understanding the application segment is crucial for Tuberculosis Testing and Diagnostics segmentation, as it helps in identifying the areas where tuberculosis testing and diagnostic products are most needed. The application segment contributes significantly to the overall market size, with diagnosis being the primary application.

The Types segment of the Tuberculosis Testing and Diagnostics market includes various subtypes such as molecular diagnostic tests, radiographic tests, and microbiological tests. Each subtype has its own set of applications and end-users, contributing to the overall market size. The types segment is vital for market taxonomy, as it helps in understanding the different technologies used in tuberculosis testing and diagnostics. The subtypes under the types segment are [object Object],[object Object], which provide a comprehensive overview of the market.

Tuberculosis Testing and Diagnostics Segmentation Breakdown11 items

Application

Hospitals and Clinics

Diagnostic Laboratories

Others

Types

Smear Microscopy

Nucleic Acid Testing

Radiography

Tuberculin Skin Test (TST)

Interferon Gamma Released Assay (IGRA)

Others

Regional Insights

Loading chart…

The Tuberculosis Testing and Diagnostics market growth is expected to vary across regions, with the Asia Pacific region being the largest, accounting for approximately 40% of the global market share. This region is also expected to be the fastest-growing, driven by key factors such as increasing adoption of advanced diagnostic technologies, government policies supporting tuberculosis control, and significant investments in healthcare infrastructure.

In North America, key drivers include a mature ecosystem with established healthcare infrastructure, a high level of awareness about tuberculosis, and ongoing research and development in diagnostic technologies. Europe is driven by factors such as favorable demographics, a strong focus on public health, and significant funding for tuberculosis research. Latin America and the Middle East & Africa regions are expected to experience growth driven by increasing infrastructure development, growing demand for diagnostic services, and expanding access to healthcare.

Regional Drivers5 items

North America: mature ecosystem, high awareness, ongoing research

Europe: favorable demographics, strong public health focus, significant funding

Asia Pacific: increasing adoption, government policies, significant investments

Latin America: infrastructure development, growing demand, expanding access

Middle East & Africa: infrastructure development, growing demand, expanding access

Competitive Landscape

The Tuberculosis Testing and Diagnostics market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Tuberculosis Testing and Diagnostics competitive landscape is driven by key players that have established strong distribution networks and invest heavily in research and development to stay ahead. Global players have a significant presence, but local companies are also gaining traction, particularly in emerging markets.

Companies in this space employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are focusing on strategic initiatives to stay competitive, as outlined below:

Roche: regional expansion

Thermo Fischer Scientific: innovation pipeline

Becton Dickinson: premium pricing

Abbott: OEM tie-ups

Hologic: local manufacturing

Qiagen: vertical integration

Key Tuberculosis Testing and Diagnostics Companies17 items

Roche

Thermo Fischer Scientific

Becton Dickinson

Abbott

Hologic

Qiagen

Sanofi

Oxford Immunotec

BioMerieux

Par Sterile

Bio-Rad Laboratories

Akonni Biosystems

Cepheid

Siemens Healthineer

Hain Lifescience

Epistem

Creative Diagnostics

Market Ecosystem

The Tuberculosis Testing and Diagnostics ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. The value chain analysis of this ecosystem reveals the interconnected roles of various stakeholders, including manufacturers, distributors, and service providers, who collectively contribute to the creation and capture of value. The ecosystem can be broadly divided into three segments: upstream, midstream, and downstream, with each segment influencing the others in terms of technology, supply, and demand.

Raw material/component suppliers — provide diagnostic reagents and equipment

OEMs / manufacturers — design and manufacture diagnostic devices

Technology providers — develop diagnostic software and algorithms

Distributors / channel partners — supply diagnostic products to healthcare facilities

Service providers / after-sales — offer maintenance and support services

End users / buyers — healthcare professionals and patients

Regulators/standards bodies — establish diagnostic standards and guidelines

The flow of value within the Tuberculosis Testing and Diagnostics ecosystem is influenced by various control points, including regulatory approvals, technology partnerships, and supply chain dependencies. The ecosystem's dependency on input materials, such as diagnostic reagents, and standards, such as those set by regulatory bodies, can create bottlenecks and risks. Furthermore, the switching costs associated with adopting new diagnostic technologies and the need for interoperability between different systems can impact the ecosystem's dynamics. The ecosystem's structure and value flow can also vary by region, with different countries having distinct regulatory frameworks, healthcare systems, and market requirements.

Recent Industry Insights

The Tuberculosis Testing and Diagnostics industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between major pharmaceutical companies and research institutions, have accelerated the development of innovative diagnostic tools. Notable mergers and acquisitions, including the acquisition of specialized diagnostic companies, have also contributed to the growth of the industry. Furthermore, the launch of advanced molecular diagnostic technologies has improved the accuracy and efficiency of tuberculosis testing.

Additionally, regulatory changes, shifts in consumer behavior, and funding rounds have influenced the Tuberculosis Testing and Diagnostics industry trends. The increasing adoption of digital health technologies and the growing demand for point-of-care diagnostic solutions are expected to drive the industry's growth in the coming years. Overall, the tuberculosis testing and diagnostics market is poised for significant expansion, driven by technological advancements, strategic partnerships, and evolving consumer needs.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Tuberculosis Testing and Diagnostics market outlook. The market attractiveness is moderate, driven by increasing demand for effective diagnostic tools. Competitive intensity is high, with several key players competing for market share. The long-term outlook is positive, with advancements in technology and innovation expected to drive growth.

The innovation landscape is evolving, with a focus on developing more accurate and rapid diagnostic tests. Demand-supply balance is currently skewed, with some regions experiencing shortages of diagnostic equipment. Key risk factors include regulatory changes and supply chain disruptions. Overall, the market presents opportunities for growth and investment, particularly in emerging economies with high tuberculosis prevalence rates.

11 items

1. Executive Summary

2. Tuberculosis Testing and Diagnostics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Tuberculosis Testing and Diagnostics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Tuberculosis Testing and Diagnostics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals and Clinics

6.1.2. Diagnostic Laboratories

6.1.3. Others

6.2. Global Tuberculosis Testing and Diagnostics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Smear Microscopy

6.2.2. Nucleic Acid Testing

6.2.3. Radiography

6.2.4. Tuberculin Skin Test (TST)

6.2.5. Interferon Gamma Released Assay (IGRA)

6.2.6. Others

6.3. Global Tuberculosis Testing and Diagnostics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Tuberculosis Testing and Diagnostics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Tuberculosis Testing and Diagnostics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Tuberculosis Testing and Diagnostics Market Competition by Key Manufacturers

8.1. Global Tuberculosis Testing and Diagnostics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Tuberculosis Testing and Diagnostics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Roche

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fischer Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Becton Dickinson

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Abbott

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Hologic

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Qiagen

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Sanofi

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Oxford Immunotec

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. BioMerieux

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Par Sterile

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Bio-Rad Laboratories

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Akonni Biosystems

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Cepheid

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Siemens Healthineer

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Hain Lifescience

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Epistem

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Creative Diagnostics

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Tuberculosis Testing and Diagnostics Market

Figure 4: Global Tuberculosis Testing and Diagnostics Market: Drivers

Figure 5: Global Tuberculosis Testing and Diagnostics Market: Challenges

Figure 6: Global Tuberculosis Testing and Diagnostics Market: Trends

Figure 7: Global Tuberculosis Testing and Diagnostics Market: Opportunity

Figure 8: Global Tuberculosis Testing and Diagnostics Market: Restraint

Figure 9: Global Tuberculosis Testing and Diagnostics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Tuberculosis Testing and Diagnostics Market Value (USD Million) By Region

Figure 15: Global Tuberculosis Testing and Diagnostics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Tuberculosis Testing and Diagnostics Market Value (USD Million) By Region

Figure 23: Global Tuberculosis Testing and Diagnostics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

87 items

Table 1: Market Segmentation Analysis

Table 2: Global Tuberculosis Testing and Diagnostics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Tuberculosis Testing and Diagnostics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Tuberculosis Testing and Diagnostics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Tuberculosis Testing and Diagnostics Market Value (USD Million) By Region

Table 10: Global Tuberculosis Testing and Diagnostics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Tuberculosis Testing and Diagnostics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Tuberculosis Testing and Diagnostics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Tuberculosis Testing and Diagnostics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Roche Basic Information And Sales Area

Table 31: Roche. Products Portfolio

Table 32: Thermo Fischer Scientific Basic Information And Sales Area

Table 33: Thermo Fischer Scientific. Products Portfolio

Table 34: Becton Dickinson Basic Information And Sales Area

Table 35: Becton Dickinson. Products Portfolio

Table 36: Abbott Basic Information And Sales Area

Table 37: Abbott. Products Portfolio

Table 38: Hologic Basic Information And Sales Area

Table 39: Hologic. Products Portfolio

Table 40: Qiagen Basic Information And Sales Area

Table 41: Qiagen. Products Portfolio

Table 42: Sanofi Basic Information And Sales Area

Table 43: Sanofi. Products Portfolio

Table 44: Oxford Immunotec Basic Information And Sales Area

Table 45: Oxford Immunotec. Products Portfolio

Table 46: BioMerieux Basic Information And Sales Area

Table 47: BioMerieux. Products Portfolio

Table 48: Par Sterile Basic Information And Sales Area

Table 49: Par Sterile. Products Portfolio

Table 50: Bio-Rad Laboratories Basic Information And Sales Area

Table 51: Bio-Rad Laboratories. Products Portfolio

Table 52: Akonni Biosystems Basic Information And Sales Area

Table 53: Akonni Biosystems. Products Portfolio

Table 54: Cepheid Basic Information And Sales Area

Table 55: Cepheid. Products Portfolio

Table 56: Siemens Healthineer Basic Information And Sales Area

Table 57: Siemens Healthineer. Products Portfolio

Table 58: Hain Lifescience Basic Information And Sales Area

Table 59: Hain Lifescience. Products Portfolio

Table 60: Epistem Basic Information And Sales Area

Table 61: Epistem. Products Portfolio

Table 62: Creative Diagnostics Basic Information And Sales Area

Table 63: Creative Diagnostics. Products Portfolio

Table 64: Global Market Value (USD Million) (2025-2032) By Application

Table 65: Global Market Share (%) By Application (2032)

Table 66: Global Market Value (USD Million) (2025-2032) By Types

Table 67: Global Market Share (%) By Types (2032)

Table 68: Global Tuberculosis Testing and Diagnostics Market Value (USD Million) By Region

Table 69: Global Tuberculosis Testing and Diagnostics Market Share (%) By Region (2025-2032)

Table 70: North America Market Value (USD Million) (2025-2032) By Country

Table 71: North America Market Value (USD Million) (2025-2032) By Application

Table 72: North America Market Value (USD Million) (2025-2032) By Types

Table 73: Europe Market Value (USD Million) (2025-2032) By Country

Table 74: Europe Market Value (USD Million) (2025-2032) By Application

Table 75: Europe Market Value (USD Million) (2025-2032) By Types

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 79: South America Market Value (USD Million) (2025-2032) By Country

Table 80: South America Market Value (USD Million) (2025-2032) By Application

Table 81: South America Market Value (USD Million) (2025-2032) By Types

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 85: Research Programs/Design For This Report

Table 86: Key Data Information From Secondary Sources

Table 87: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Tuberculosis Testing and Diagnostics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.90 million
Revenue forecast in 2033	18.35 million
Growth rate	CAGR of 4.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Thermo Fischer Scientific; Becton Dickinson; Abbott; Hologic; Qiagen; Sanofi; Oxford Immunotec; BioMerieux; Par Sterile; Bio-Rad Laboratories; Akonni Biosystems; Cepheid; Siemens Healthineer; Hain Lifescience; Epistem; Creative Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options